RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,150 | -57.4% | 350,000 | 0.0% | 0.00% | -62.5% |
| Q2 2023 | $385,000 | -7.6% | 350,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $416,500 | -59.5% | 350,000 | -49.3% | 0.01% | -61.9% |
| Q4 2022 | $1,028,100 | -8.6% | 690,000 | 0.0% | 0.02% | -12.5% |
| Q3 2022 | $1,125,000 | +104.9% | 690,000 | 0.0% | 0.02% | +118.2% |
| Q2 2022 | $549,000 | -55.8% | 690,000 | 0.0% | 0.01% | -45.0% |
| Q1 2022 | $1,242,000 | +5.3% | 690,000 | 0.0% | 0.02% | +11.1% |
| Q4 2021 | $1,180,000 | +13.5% | 690,000 | +36.6% | 0.02% | +12.5% |
| Q3 2021 | $1,040,000 | -8.1% | 505,000 | +3.1% | 0.02% | -5.9% |
| Q2 2021 | $1,132,000 | – | 490,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |